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METHODS: We analyzed the 2004 German InEK Hospital sta-
tistics data, the 2005 French Programme de Médicalisation des
Systèmes d’Informations (PMSI) database and the 2005–06 NHS
England Hospital Episode Statistics (HES) database to estimate
the number and type of surgical procedures for POP. We included
procedures performed for uterovaginal prolapse, such as col-
porrhaphy, sacrocolpopexy and sacrospinous colpopexy. Addi-
tionally, we identiﬁed the total number of hysterectomies;
extrapolating from previous studies, we assumed 15% of these
were performed for a primary indication of POP. We multiplied
the observed number of surgical procedures by the respective
2007 Diagnosis-Related Group (DRG) reimbursement rates to
estimate the direct annual surgical cost. RESULTS: Annually,
62,581 POP repair procedures were performed in Germany,
32,392 in France and 23,583 in NHS England. In addition, we
estimate that 39,329 hysterectomies are performed for a primary
indication of POP across the three healthcare systems. The direct
surgical cost of these surgical procedures was €476M. CON-
CLUSIONS: The annual direct surgical cost of POP to the 3 big
European healthcare systems is nearly €500M, highlighting a sig-
niﬁcant burden to the European payer. This is under-estimate of
the true cost of the illness because it does not include other
medical costs, cost of conservative management and societal
costs. Extrapolating from epidemiological studies, about 30% of
POP procedures are repeat surgeries, implying the direct surgi-
cal cost of re-operations is approximately €135M. Considering
the high ﬁnancial burden of POP and its recurrence, it is imper-
ative that new standardized procedures with superior outcome
are considered, in order to effectively treat the condition, and by
doing so, reduce recurrence.
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OBJECTIVES: In 2001, excessive uterine bleeding was the cause
of 1.4 million physician visits in the US. Beyond offering con-
traceptive beneﬁts, Levonorgestrel-Releasing Intrauterine System
(LNG-IUS) is an effective alternative to traditional management
of menstrual bleeding disorders. The objective was to describe a
population on LNG-IUS and assess contraceptive and non-
contraceptive outcomes. METHODS: Women °Y´18 years of age
with LNG-IUS and °Y´1 year of continuous enrollment pre- and
post-insertion were identiﬁed via a retrospective cohort design
utilizing claims data from a Michigan vertically integrated health
care system (Jan. 2000–Dec. 2005). Patterns of LNG-IUS use,
number of obstetric- and gynecology-related visits, percent of
patients with menorrhagia, dysmenorrhea, dysfunctional uterine
bleeding, and abnormal uterine bleeding were compared pre- and
post-insertion, along with gynecology-related costs. RESULTS:
A total of 152 women (mean age 35 ± 8) met study inclusion
criteria. Two nested cohorts were distinguished further based on
follow-up length as 2-year pre/post (N = 73) and 3-year pre/post
(N = 29) groups. Over 90% had a single insertion and °Ü4% a
LNG-IUS -related complication (e.g. expulsion, perforation, or
infection). No LNG-IUS patient experienced a pregnancy with
no obstetric-related visits post-insertion for all groups. Thirteen
percent of women experienced menorrhagia in the year preced-
ing insertion, down to 12.5%, 1.2% and 0% in the 1, 2 and 3
years post-insertion. Subsequently, mean number of gynecology-
related visits decreased from 4 to 2; 7 to 4 and 9 to 4 from the
pre- to the post-insertion period for the 1, 2, and 3-year follow-
up groups, respectively. Among non-hysterectomized women,
mean gynecology-related costs decreased from $1646 per patient
in the 3 years preceding LNG-IUS to $1355 in the 3 years post-
insertion. CONCLUSION: LNG-IUS avoided pregnancy in all
patients and led to decreased bleeding-related events and gyne-
cology-related costs starting in the second year post-insertion.
Beneﬁts should become more apparent with longer follow-up.
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OBJECTIVES: Benzodiazepines are commonly prescribed for
older people. As the elderly are more susceptible to potential
adverse outcomes from benzodiazepines, it is recommended that
benzodiazepines be used for short periods with a reduced dosage.
This observational study aimed to investigate benzodiazepine
use, in terms of treatment period and mean dosage, and examine
characteristics associated with use. METHODS: This was an
observational study of randomly selected subjects enrolled in the
National Health Insurance program, aged at least 65, who
received at least one prescription for benzodiazepines in 2002.
They were grouped according to treatment period and mean
dosage. The treatment period was deﬁned as the number of days
covered by prescribed benzodiazepines. The mean dosage was
deﬁned by the average deﬁned daily dose (DDD) of each indi-
vidual. An ordered logit regression model was adopted to eval-
uate associations of characteristics with benzodiazepine usage.
RESULTS: Of the 17,024 elderly persons included, a total of
7451 had received at least one prescription for benzodiazepines.
Individuals with comorbid mental disease such as insomnia,
anxiety, and depression, and comorbid physical disease such as
cardiovascular disease, cancer, and renal disease, and previous
receipt of benzodiazepines were more likely to receive benzodi-
azepine prescriptions. Those older than 75 years, male, with
insomnia, anxiety, depression, mental disease, physical disease
such as cardiovascular disease and diabetes, previous receipt of
benzodiazepines, and higher prescription-overlap ratio were
more likely to receive longer treatment. Subjects with insomnia,
anxiety, depression, other mental disease, arthritis, previous
receipt of more benzodiazepines, and higher prescription-overlap
ratio were more likely to receive higher-dose therapy. CON-
CLUSION: According to our preliminary ﬁndings, the one-year
prevalence of benzodiazepine use among the elderly was approx-
imately 44%. Mental disorders, previous exposure to more 
benzodiazepine, and higher prescription-overlap ratio were asso-
ciated with both longer treatment and higher mean daily dose.
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OBJECTIVES: With the implementation of Medicare Part D,
managed care plans have aggressively marketed their offerings,
potentially expanding the proportion of beneﬁciaries enrolled in
Medicare managed care, known as Medicare Advantage (MA).
Growth in MA penetration has potentially important implica-
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tions for both patients and providers, yet has received little atten-
tion since Part D went into effect. Our objective was to deter-
mine the impact of Medicare Part D on MA enrollment.
METHODS: State-level data from the Centers for Medicare 
and Medicaid Services (CMS) were used to calculate overall
Medicare enrollment (including dual eligibles), enrollment in
managed care plans, and enrollment in MA plans with drug cov-
erage (MA-PDs) and stand-alone prescription drug plans (PDPs)
from January 2003–June 2006. States were classiﬁed as having
low, medium, or high penetration based on tertile of penetration
for the ﬁrst quarter of 2003 (1Q03). The effect of Part D on
managed care enrollment penetration in states with low,
medium, and high penetration was assessed using linear regres-
sion. RESULTS: Nationwide, MA penetration increased from
14.0% in 4Q05 to 15.3% in 2Q06. MA penetration signiﬁcantly
increased following the implementation of Part D, but only in
states which had low Medicare managed care penetration prior
to Part D (p < 0.05). CONCLUSION: New MA enrollees living
in areas that historically had little experience with managed care
may face interruptions in health care or difﬁculties accessing
care, at least initially. CMS should carefully monitor the health
care patterns of new MA enrollees to ensure that beneﬁciary
health is not compromised.
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OBJECTIVES: Medication nonadherence is an important
problem in older populations, and is affected by numerous
factors. The aim of this study was to examine the relationship
between gender and medication adherence in older adults 
with chronic diseases. METHODS: A longitudinal cohort 
study was conducted in older adults (aged >65 years) who com-
pleted a health status assessment and were enrolled in a health
maintenance organization. The study sample included patient
cohorts with four major chronic diseases. Medication Possession
Ratio (MPR) was used as a measure of medication adherence 
in Type 2 Diabetes Mellitus (n = 775 patients), asthma (n =
129 patients), and overactive bladder (OAB) (n = 275 patients).
Persistence rate was used as the measure of medication 
adherence in glaucoma (n = 268 patients). RESULTS: For glau-
coma patients, males had a signiﬁcant 0.111-point (22.2%
increase over mean) decrease in medication persistence (p <
0.05). In male asthma patients, there was a similar 0.13-point
(38% increase over mean) decrease in medication adherence as
measured by the Med-Total score (p < 0.05). A 0.0051-point
increase (0.8% increase over mean) in MPR was found in male
patients receiving continuous antidiabetic pharmacotherapy (p >
0.05). In male OAB patients, there was a 0.025-point increase
(6% increase over mean) in MPR for antimuscarinic medications
(p > 0.05). CONCLUSION: This study found signiﬁcant but
unexplained associations between male gender and decreased
medication adherence in glaucoma and asthma patients. No sig-
niﬁcant adherence differences were found between males and
females for Type 2 diabetic and OAB patients. This suggests 
that gender can be a predictor of medication adherence but this
effect varies depending on which chronic disease the patient
suffers from. Further study of these gender differences is war-
ranted in order to improve medication adherence and aid in
disease intervention.
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OBJECTIVES: Although several studies have described the
burden of Premenstrual Dysphoric Disorder (PMDD) impacts
women’s lives, few undertook a quantitative approach. This
study is an attempt to quantify the burden of PMDD on health-
related quality of life (HRQoL) in comparison to speciﬁc chronic
conditions in the US general population. METHODS: The
burden of PMDD on HRQoL was estimated by comparing SF-
12 scores between women identiﬁed as being “at risk for
PMDD” with SF-12 scores observed in the general US popula-
tion. Additional comparisons were made to several chronic
health conditions. SF-12 normative values of the general popu-
lation were estimated through regression adjusted to match the
age and disease comorbidity of the PMDD patient group. Sig-
niﬁcance tests between the means across samples were compared.
Medical expenditures were estimated and compared for women
who were “at risk for PMDD” and women with no reported
chronic conditions. RESULTS: All SF-12 measures of PMDD
were signiﬁcantly below the adjusted US general population
norms. The burden of PMDD was greater on mental/emotional
than on physical HRQoL. The burden of PMDD on HRQoL was
greater than that of chronic back pain; similar to type 2 diabetes,
hypertension, osteoarthritis and rheumatoid arthritis; and largely
comparable to depression. Age, PCS, and MCS scores were used
to predict monthly medical expenditures using data from the
annual Medical Expenditures Panel Survey (2001). The mean
predicted monthly medical expenditure for women “at risk for
PMDD” was $222.3 (SD = $107.3) and $134.0 (SD = $43.4) for
women with no reported chronic conditions (p < 0.0001). CON-
CLUSION: PMDD is associated with substantial burden on
physical and mental aspects of HRQoL, and may be related to
increased medical expenditures.
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OBJECTIVES: Many of the large ongoing national surveys of
the US population contain a question that asks for the respon-
dent’s self-reported health status: “excellent,” “very good,”
“good,” “fair” or “poor.” These surveys could be used to con-
duct cost-utility analyses of health care policies, treatments 
or other interventions if quality-of-life (QOL) weights for the
self-reported health statuses were also available. The objective of
this study was to produce nationally representative QOL weights
for self-reported health status and for 10 priority health condi-
tions, by a series of demographic variables. METHODS: The
Medical Expenditure Panel Survey contains the questions from
the EQ-5D health status measure. A recent study has calculated
time-trade-off-derived QOL weights corresponding to the EQ-
5D health states for a large US sample. We use these data to con-
struct QOL weights for the ﬁve self-reported health status
categories and 10 priority health conditions, by a series of demo-
graphic variables. RESULTS: Mean and median QOL weights
were produced for self-reported health status, the 10 priority
